Lexaria Bioscience Statistics
NASDAQ: LEXXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.32-0.04 (-1.19%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lexaria Bioscience by the numbers
Lexaria Bioscience has a market capitalization of $7.0 million based on 2.11M shares outstanding. With trailing EPS of $-5.10, Lexaria Bioscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.6% below its 50-day average and 65.0% below its 200-day average.
Average daily trading volume is 65.40K shares, or about $217,125 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LEXX valuation vs. peer median
| Metric | LEXX | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.99M | $6.91M | +1% |
| Avg. volume | 65.40K | 113.36K | -42% |
Peer median across 8 companies: NRSN, ACXP, XCUR, TRAW, INM, SKYE, ENVB, ALZN.
Valuation
- Market cap
- $6.99M
- EPS (TTM)
- $-5.10
- Shares outstanding
- 2.11M
Price and trading
- Previous close
- 3.36
- Open
- 3.31
- Day range
- 3.12 – 3.90
- 52-week range
- 2.77 – 21.60
- Beta
- —
- Volume
- 198.41K
- Average volume
- 65.40K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jul 10, 2025
Additional statistics
- Market Cap
- 6.99M
- Forward Pe
- -8.51
- Eps
- -5.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.60
- Week52 Low
- 2.77
- Avg Volume
- 65,399.00
- Shares Outstanding
- 2.11M
- Ma50
- 6.59
- Ma200
- 9.48
- Earnings Date
- Jul 10, 2025
- Pct From52w High
- -84.63%
- Pct From52w Low
- 19.86%